Publications by authors named "Corey Wyrick"

Claim this Profile
Î
γδ T Cells Control Gut Pathology in a Chronic Inflammatory Model of Colorectal Cancer.
Suryasarathi Dasgupta, Hong Liu, Brandi Bailey, Corey Wyrick, Jessica Grieves

Cell Mol Gastroenterol Hepatol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "Discovery of the Bruton's Tyrosine Kinase Inhibitor Clinical Candidate TAK-020 ()-5-(1-((1-Acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-2,4-dihydro-3-1,2,4-triazol-3-one, by Fragment-Based Drug Design".
Mark Sabat, Douglas R Dougan, Jacques Ermolieff, Petro Halkowycz, Beverly Knight, Corey Wyrick

J Med Chem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of the Bruton's Tyrosine Kinase Inhibitor Clinical Candidate TAK-020 ()-5-(1-((1-Acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-2,4-dihydro-3-1,2,4-triazol-3-one, by Fragment-Based Drug Design.
Mark Sabat, Douglas R Dougan, Beverly Knight, J David Lawson, Nicholas Scorah, Corey Wyrick

J Med Chem· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of TAK-659 an orally available investigational inhibitor of Spleen Tyrosine Kinase (SYK).
Betty Lam, Yasuyoshi Arikawa, Joshua Cramlett, Qing Dong, Ron de Jong, Corey Wyrick

Bioorg Med Chem Lett· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton's Tyrosine Kinase.
Christopher R Smith, Douglas R Dougan, Mallareddy Komandla, Toufike Kanouni, Beverly Knight, Corey Wyrick

J Med Chem· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis